Revenue up 5.4 per cent as home, health and personal care categories show steady growth
Dabur India reported a 6.48 per cent year-on-year rise in consolidated net profit to Rs 452.55 crore for the quarter ended 30 September 2025, compared with Rs 425 crore in the same period last year.
Revenue from operations grew 5.37 per cent to Rs 3,191.32 crore, supported by steady demand across categories. Profit before tax rose nearly 5 per cent to Rs 573.02 crore from Rs 545.96 crore in Q2 FY25, while total expenses increased 4.7 per cent to Rs 2,758.33 crore.
The company reported growth across major verticals, including health supplements, oral care, hair care, skincare, and home care. The toothpaste category led the performance with a 14.3 per cent year-on-year rise, driven by Dabur Red Paste and premium brand Meswak. The Real Activ fruit juice portfolio surged over 45 per cent, while the foods segment expanded more than 14 per cent.
In personal care, shampoo sales rose over 9 per cent, hair oils grew more than 5 per cent, skincare and salon products advanced around 8 per cent, and home care saw over 5 per cent growth.
Dabur’s international business increased 7.7 per cent year-on-year, supported by strong performance in key markets. The company reported over 17 per cent growth in Dubai, 48 per cent in the UK, and around 16 per cent each in Bangladesh and the US. Turkey also posted an 18 per cent rise in sales.
During the quarter, Dabur’s board approved the formation of Dabur Ventures, a new investment vehicle with a fund allocation of up to Rs 500 crore. The platform will invest in high-potential, digital-first, and emerging consumer businesses, fully funded through the company’s balance sheet.
“Our performance during the quarter stands as a testament to Dabur’s enduring resilience and consumer trust. Despite a dynamic economic environment and transitional GST headwinds, we delivered robust topline and bottomline growth, reaffirming our leadership across core categories,” said Mohit Mathotra, Chief Executive Officer, Dabur India.
The board also declared an interim dividend of 275 per cent or Rs 2.75 per share, translating to a total payout of Rs 487.76 crore, in line with its consistent shareholder return policy.
Dabur, one of India’s leading FMCG and Ayurvedic healthcare companies with a strong global presence, saw its shares fall 2.11 per cent to Rs 490.75 on the BSE.
